Printer Friendly

RIKEN Elucidates Inactivation Mechanism of Gibberellin, Plant Growth-promoting Hormone.

Tokyo, Japan, Feb 1, 2006 - (JCN) - RIKEN announced on January 30 that its Plant Science Center has discovered an inactivation mechanism of gibberellin, a kind of hormone that promotes plant growth, in collaboration with Shanghai Institutes for Biological Sciences (SIBS).

The two organizations have conducted research using the eui (elongated uppermost internode) mutant of rice, which has a longer internode than conventional rice. The joint research group has elucidated that cytochrome P450 oxidase, a protein expressed in eui genes, suppresses the activity of gibberellin.

In addition, the group has confirmed that gibberellin is excessively accumulated in the eui mutant.

RIKEN expects that these findings will contribute to the development of plant growth regulating technologies using growth-promoting hormones. Details of this discovery will be published in the February issue of US scientific magazine The Plant Cell.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Feb 2, 2006
Words:145
Previous Article:Interwired Surveys Flower Purchasing Habits.
Next Article:Astellas Pharma, Ferring Pharmaceuticals Sign Licensing Agreement for Degarelix, Prostate Cancer Agent.


Related Articles
Where the daminozide is.
How does your garden grow roots?
Quantitatively determine pathogen reduction.
National Institute of Agrobiological Sciences, RIKEN Co-Develop DNA Book of 30,000 Rice Genomes.
Riken Vitamin to Bring to Market No-Oil/Cholesterol Mayonnaise in February.
Cellular, molecular and developmental biology.
RIKEN Elucidates Reaction Mechanism of Indoleamine 2,3-Dioxygenase.
RIKEN Finds Reveromycin A Effective in Treating Osteoporosis.
RIKEN Research Center for Allergy and Immunology Discovers Mechanism for Regulating Immune Response.
Riken Discovers New Mechanism for Controlling Allergic Reactions.

Terms of use | Privacy policy | Copyright © 2024 Farlex, Inc. | Feedback | For webmasters |